I wish NervGen would post more updates on how the research is going. Use of AI for drug trials should definitely improve the speed of delivery against competitors. If they are not adapting to using new tools and technologies available, the opportunity to deliver innovation may be lost. Rooting for this company!
C and D occur in people with spinal cord lesions caused by disease rather than injury. I have myelopathy due to a hernia in the cervical spine and I am right between C and D. More than C but less than D.
I wish NervGen would post more updates on how the research is going. Use of AI for drug trials should definitely improve the speed of delivery against competitors. If they are not adapting to using new tools and technologies available, the opportunity to deliver innovation may be lost. Rooting for this company!
I hope this drug breaks the LONG TIME CURSE of SCI 🙏
I’m hoping this can help with remylenation in MS too! I have an MS lesion in my brain stem that has me using a chair full time.
Quando chegará ao Brasil? Ou Quando podermos comprar?
Are you currently seeking volunteers for the Shirley Ryan trial?
They are recruiting volunteers search clinical trails by nervgen u will find details there.
India me kab tak ayega
🙏
Only asia c and d? This is useless most people with sci are A and B
C and D occur in people with spinal cord lesions caused by disease rather than injury. I have myelopathy due to a hernia in the cervical spine and I am right between C and D. More than C but less than D.
❤❤❤❤